Filtered By:
Specialty: Laboratory Medicine
Procedure: Percutaneous Coronary Intervention
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
Conclusions: High baseline serum sLOX-1 concentration predicts 2-year MACCEs and shows an additional prognostic value to conventional risk factors in patients after primary PCI. sLOX-1 determination might play a complementary role in the risk stratification of patients with CAD treated with PCI.
PMID: 31772687 [PubMed - in process]
Source: Disease Markers - November 29, 2019 Category: Laboratory Medicine Tags: Dis Markers Source Type: research
